Resultados de la búsqueda 21-30 of 1918 for Proliferation

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...

  5. Nefrología e hipertensión - Ensayos clínicos - Mayo Clinic

    Daratumumab for Treatment of Proliferative Glomerulonephritis With Monoclonal Immune Deposits (PGNMID). Rochester, Minn., Jacksonville, Fla. The purpose of ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. A Study to Test the ...

  8. Nefrología e hipertensión - Ensayos clínicos

    ... proliferation and contributing to cystogenesis. A Study to Compare Urinary Exosomes in Healthy Kidney Donors and Renal Transplant Recipients. Rochester, Minn ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Testing the Addition of ...